A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19

Mostrar otras versiones (1)

The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemzadeh, Nima, Kim, Nathan, Amlani, Shy, Madan, Mina, Shavadia, Jay S., Chong, Aun-Yeong, Bagherli, Alireza, Bagai, Akshay, Saw, Jacqueline, Singh, Jyotpal, Dehghani, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973551/
https://www.ncbi.nlm.nih.gov/pubmed/36863811
http://dx.doi.org/10.1016/j.hfc.2022.08.007
Descripción
Sumario:The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.

Ejemplares similares